Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
0.6980
+0.0652 (10.30%)
Jul 25, 2025, 3:59 PM EDT
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $241.37 million as of July 25, 2025. Its market cap has decreased by -58.81% in one year.
Market Cap
241.37M
Enterprise Value
665.16M
Revenue
697.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 241.37M, a decrease of -61.56%. That is a compound annual growth rate of -13.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 241.03M | -24.68% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.81M |
| Glass House Brands | 416.79M |
| Northwest Biotherapeutics | 382.85M |
| CytoDyn | 376.49M |